Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells
Authors not listed
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus · 2022
Abstract
Treatment of age-related macular degeneration using retinal stem and progenitor cells
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-09 MST
Cite this
APA
Anonymous. (2022). Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells. <em>Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus</em>. https://clinicaltrials.gov/study/NCT05187104
Vancouver
Anonymous. Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells. Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus. 2022.
BibTeX
@misc{anon2022Treatm,
title = {Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells},
author = {Anonymous},
journal = {Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus},
year = {2022},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature reviews. Immunology 2013
Preprint · OA
Immunology of age-related macular degeneration
Drugs & Aging 2002
Citation only
Age-Related Macular Degeneration
Advances in experimental medicine and biology 2012
Citation only
Age-Related Macular Degeneration
Ophthalmology 2014
Citation only
Age-Related Macular Degeneration
Primary Care Clinics in Office Practice 2015
Citation only
Age-Related Macular Degeneration
Survey of Ophthalmology 1998
Citation only